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S U M M A R Y
Objectives: Characterize a NDM-1 producing K. pneumoniae isolate recovered from a patient hospitalized
in Guadeloupe, French West Indies, after its transfer from Cuba
Methods: Antibiotic susceptibilities were determined by the disk diffusion method, and E-test.
Carbapenemase production was assessed using the Carba NP test. Antibiotic resistance determinants and
their surrounding structures were characterized by PCR mapping and DNA sequencing. Transfer of the b-
lactam resistance marker was attempted by liquid mating-out assays
Results: Here we reported the ﬁrst NDM-1 producing enterobacterial isolate recovered from Caribbean
islands. This K. pneumoniae isolate belongs to a new sequence type (ST1649). The blaNDM-1 gene together
with the aacA4 gene were carried on a self conjugative IncR plasmid of c.a. 80 kb.
Conclusion: This study describes the ﬁrst identiﬁcation of a NDM-1 producer in Caribbean islands. The
uncommon incompatibility group of the blaNDM-1 carrying plasmid and the uncommon ST type of the K.
pneumoniae strain suggest a possible local emergence of NDM producers.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idThe metallo-b-lactamase (MBL) group of enzymes are carba-
penemases that inactivate most of the b-lactam molecules except
aztreonam, and are frequently associated with genes conferring
resistance to several other classes of antibiotics. Among the MBLs,
the New Delhi metallo-b-lactamase-1 (NDM-1) was ﬁrst described
in a Klebsiella pneumoniae isolate.1 Initially, the spread of NDM-1
was mostly identiﬁed from the Indian sub-continent.2 Since then,
NDM-1 producers have been described worldwide.2 Here, we
report the emergence of a NDM-1 producing K. pneumoniae
recovered from a patient hospitalized in Guadeloupe, French West
Indies after its transfer from Cuba.* Corresponding author. Service de Microbiologie, Centre Hospitalier Universi-
taire de Pointe-a`-Pitre / Abymes, 97159 Pointe-a`-Pitre cedex, Guadeloupe, France.
Tel.: +0590 590 89 12 69; fax: +0590 590 89 11 56.
E-mail address: sylvaine.bastian@chu-guadeloupe.fr (S. Bastian).
http://dx.doi.org/10.1016/j.ijid.2015.03.002
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).In June 2014, a 67-year-old German traveler was hospitalized in
La Havana, Cuba, for an ischemic cerebrovascular failure. On day 8,
the patient developed a pneumonia that was empirically treated
with ceftazidime, ciproﬂoxacin, and metronidazole. The clinical
status of the patient worsened necessitating intubation and
mechanical ventilation on day 11, and his transfer on day 15 to
the intensive care unit of the University hospital of Pointe-a`-Pitre,
Guadeloupe, France. As recommended for the detection of
carbapenemase producers,3 a rectal swab was collected at
admission, leading to the isolation of the multidrug resistant K.
pneumoniae KHU strain.
Antimicrobial drug susceptibilities were determined by the disk
diffusion method and interpreted according to the Clinical
Laboratory Standards Institute (CLSI) guidelines as updated in
2014.4 The minimal inhibitory concentrations (MICs) were
determined by using E-test (bioMe´rieux, La Balme-les-Grottes,
France) on Mueller-Hinton agar at 37 8C. The K. pneumoniae KHUciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
MICs of b-lactams for K. pneumoniae KHU clinical isolate and the transconjugant
E. coli J53 harboring the natural plasmid from K. pneumoniae KHU
b-Lactam (s)a K. pneumoniae KHU Tcb E. coli J53
Amoxicillin > 256 > 256
Amoxicillin +CLA > 256 > 256
Ticarcillin > 256 > 256
Ticarcillin + CLA > 256 > 256
Piperacillin > 256 128
Piperacillin + TZB > 256 128
Ceftazidime > 256 > 256
Cefotaxime > 256 > 256
Cefepime > 256 64
Cefoxitin > 512 > 512
Aztreonam 0.12 0.12
Imipenem 16 6
Meropenem 32 6
Ertapenem 32 4
Doripenem 12 6
a CLA, clavulanic acid; TZB, tazobactam, at 4 mg/ml.
b transconjugant.
S. Bastian et al. / International Journal of Infectious Diseases 34 (2015) 53–5454was resistant to all b-lactams except aztreonam, including
imipenem (MIC = 16 mg/mL), meropenem (MIC = 32 mg/mL), erta-
penem (MIC = 32 mg/mL) and doripenem (MIC = 12 mg/mL)
(Table 1). It was also resistant to all aminoglycosides except to
amikacin, to ﬂuoroquinolones, to trimethoprim-sulphamethoxa-
zole, to doxycycline, and to tetracycline but remained susceptible
to colistin, fosfomycin, and tigecycline. In addition, three other
multidrug resistant strains were isolated as a carrier stage, an
extended-spectrum b-lactamase (CTX-M-15) producing Escher-
ichia coli, a methicillin-resistant Staphylococcus aureus and an
OXA-23 producing Acinetobacter baumannii. To the contrary of the
NDM-1 producing K. pneumonia, the latter two bacteria also were
isolated in the respiratory secretions.
Using the Carba NP test,5 a carbapenemase activity was rapidly
detected. Then PCR ampliﬁcation followed by sequencing on
whole-cell DNA as described,6 identiﬁed the blaNDM-1 gene
together with the aacA4 gene encoding the AAC(6’)-Ib acetyl-
transferase that confers high-level resistance to aminoglycosides,
except to amikacin. PCR for the blaCTX-M, blaTEM, blaOXA-1, blaOXA-9
and blaOXA-10 genes were negative. Multi-locus sequence typing
(MLST) analysis showed that the K. pneumoniae KHU isolate
belonged to a new sequence type (ST) variant, ST1649, that is single
locus variant of ST129 that has never been associated with NDM
producers.
Plasmid DNA of K. pneumoniae KHU was extracted and analyzed
using the Kieser method, as described.7 Two plasmids were
identiﬁed, being ca. 80-kb and 160-kb in size. Transfer of the
b-lactam resistance marker into E. coli J53 was attempted by liquid
mating-out assays at 37 8C. E. coli transconjugants were obtained
being resistant to all b-lactams except aztreonam, including to
carbapenems (MICs of imipenem, meropenem, ertapenem, and
doripenem were 6, 6, 4, and 6 mg/mL, respectively) (Table 1). They
harbored a ca. 80-kb plasmid carrying the blaNDM-1 and aacA4
genes. PCR-based replicon typing method was performed as
described,8 and showed that this blaNDM-1-positive plasmid
belonged to the IncR incompatibility group. Although blaNDM-1
carrying is usually located on IncA/C-, IncF-, IncL/M-, IncN2-,
IncH1B- or untypable-type plasmids,3 an IncR blaNDM-1 carryingplasmid has been recently reported in Czech Republic.9 Genetic
structures surrounding the blaNDM-1 gene, performed by PCR
mapping as previously described,6 identiﬁed a truncated insertion
sequence ISAba125 and the bleomycin resistance gene bleMBL
upstream and downstream of the blaNDM-1 gene, respectively. The
same genetic environment is known for most NDM-1-producers in
Enterobacteriacae.6
This study describes the identiﬁcation of a NDM-1 producer in
Caribbean islands. As the patient was a traveler from Germany, an
intestinal colonization before travelling to Cuba cannot be
excluded. However, the patient had never been hospitalized
before, which is the most important risk factor for multidrug
resistant bacteria acquisition.2 No apparent link of this patient
with the Indian subcontinent was established. Combined with the
uncommon incompatibility group of the blaNDM-1 carrying plasmid
and the uncommon ST of the K. pneumoniae strain, all these
elements suggest a local emergence of NDM-1 producers. This is of
major concern as Cuba is considered a major hub for all forms of
human migrations, to and from the United States, Europa and other
Caribbean islands. Furthermore, few hospitals in Cuba can
implement all the measures necessary to prevent nosocomial
infections but also act as a barrier between the community and the
hospital.10 Further work shall determine the prevalence rate of
NDM and carbapenemase producers in Cuba to search for a
possible endemicity of this multidrug resistance trait.
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